The Challenges Sample Clauses

The Challenges. The Parties acknowledge the following:
AutoNDA by SimpleDocs
The Challenges. The Product/Solution should solve business challenges for one of the following three areas within the payment landscape: ● Challenge #1: Advancing Next-Gen Payment experiences ● Challenge #2: Empowering merchants and SMEs ● Challenge #3: Unlocking new payment flows ● Challenge #4: Building a smart and sustainable future ● Challenge #5: Embedded Finance
The Challenges. The Product/Solution should solve business challenges for one of the following three areas within the payment landscape in Bulgaria or Greece: ● Challenge #1: Advancing Next-Gen Payment experiences ● Challenge #2: Empowering SMEs ● Challenge #3: Unlocking new payment flows ● Challenge #4: Building a smart and sustainable future Article 5 - Program Phases and Timelines ● Phase 1: 20 Jan - 14 March: Applications submission and invitation by the Organizer/ Visa ● Phase 2: Review and Selection ○ 14 March - 31 March 2022 - Program fintechs review and shortlisting ○ 7 April 2022Selection Day ○ 14 April 2022 – Kick Off ● Phase 3: Main Program Curriculum and PoC Support ○ May 2022 - October 2022 - Discovery Days, Design Sprints, Work with Mentors, Experts, Clients and PoC Partners, PoC Support ● Phase 4: November 2022 - Demo Day The timelines above are indicative and the Organizer reserves the right to amend or modify the Program calendar if the circumstances require such changes. In such a case, the amendment or modification of the Program will be published on the Website.
The Challenges. As the power balance has shifted, and customers have had to change the way they take part in creating their own package of support, a number of challenges have arisen. These challenges have included: • Opening up to person-centred thinking, which in many cases has reminded customers of their lives before they became ill. It has validated their talents and abilities, and has sparked interest in reviving old hobbies and skills. One customer, for example, astonished staff by talking about her teenage tennis championships, and followed this up with a commitment in her plan to taking it up again. Despite repeated pleas from her psychiatrist that the customer should exercise as a preventative measure against relapse, this was the first time that she had showed any motivation or interest in doing so • Taking control of their lives, where previously others have taken responsibility. This includes the challenge of thinking creatively about the support that they need and working out how to deal with greater choice. This can go way beyond customers’ comfort zones and needs skilled facilitation • Maintaining focus and motivation after the buzz of person-centred planning fades. This was helped by regular exercise of control (e.g. purchasing support frequently) and outcome based reviews which help customers to see what they have achieved and how much more they could do • Having the confidence to say which worker they would like to be supported by and overcoming concerns that workers they don’t choose might be offended or upset. This was mitigated by ensuring any customer could arrange their support directly with any member of staff • Having the confidence to ask workers to work shifts on specific days and times so that support can be delivered to suit them. When it is tried, however, it works well, such as when customers request particular members of staff to come in at a later time so that they can go out to the cinema or for a meal together • Recognising that the cash allocation is to meet eligible and assessed support needs, not to meet unrelated living expenses, such as general cash when running short, or for housing related bills • Managing cash, using cash allocations to meet agreed outcomes and returning receipts. There have, to date, been no examples of unaccounted spend, and perhaps unsurprisingly, many customers have been more diligent with the personalisation money and receipts than they normally are with their own money.
The Challenges. The Product/Solution should solve business challenges for one of the following three areas within the healthcare landscape in Bulgaria: • Challenge #1: Building the future smart pharmacy • Challenge #2: Save, healthy and integrated elderly society • Challenge #3: Life-long digital health management Article 5 - Program Phases and Timelines ● Phase 1: 2.05. - 7.06.2019 - Application submissions and invitation by the Organizer/ STR ● Phase 2: 8.06. - 14.06.2019 - Candidates review and selection processPhase 3: 17.07. - 18.08. 2019 - The Program Sessions and Design sprints
The Challenges. Buffalo City has very few waste diversion activities driven by the public sector. The Call-2-Action Initiative (launched in 2016 by businesses in the city and led by the Border-Kei Chamber of Business) included waste management activities in their aim to improve living conditions in the city, although much of the focus was on litter cleaning and beautifying, with four sites for recycling also identified. At the time, Buffalo City had no operational public drop-off facilities and the bulk of the waste generated in the municipality was going to landfill. Some of the challenges that hampered the establishment of recycling facilities in the municipality were: • Availability of land; • capacity within the municipality for operation of a drop-off/recycling facility • limited understanding of the economic viability of recycling operations. • lack of infrastructure for recycling, The Solutions Sorting of recyclables at buyback centres In 2021, the non-profit company Polyco, a plastic focused producer responsibility organisation (PRO), agreed to partner with Buffalo City and the Border-Kei Chamber of Business to implement a solution that would improve the collection of recyclables, and increase the recycling capacity in Buffalo City. The Buffalo City Development Agency, Border Kei Chamber of Business and Polyco partnered to pilot the establishment of hybrid drop-off and buyback centre operations at four sites: SETTLERS WAY OXFORD STREE

Related to The Challenges

  • Challenges The Experts may be challenged by either Party if circumstances exist that give rise to justifiable doubts as to any of their impartiality or independence. In such circumstances the challenge shall be brought by written notice to the ICC copied to the other Party within fourteen (14) calendar days of the appointment of the relevant Expert or within fourteen (14) calendar days of the challenging Party becoming aware of the circumstances giving rise to the challenge. Unless the challenged Expert withdraws. or whichever of the Parties that has not brought the challenge agrees to the challenge, within fourteen (14) calendar days of the challenge, the ICC shall decide the challenge and, if appropriate, shall appoint a replacement Expert in accordance with the criteria set out herein.

  • No Challenges Each Shareholder agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, Merger Sub, the Company or any of their respective successors or directors (a) challenging the validity of, or seeking to enjoin the operation of, any provision of this Agreement or the Merger Agreement or (b) alleging a breach of any fiduciary duty of any person in connection with the evaluation, negotiation or entry into the Merger Agreement.

  • Challenge If Executive violates or challenges the enforceability of any provisions of the Restrictive Covenants or this Release, no further payments, rights or benefits under Section 5 of the Agreement will be due to Executive (except where such provision would be prohibited by applicable law, rule or regulation).

  • Legal Action If you are dissatisfied with the determination of your claim, and have complied with applicable state and federal law, you are entitled to seek judicial review. This review will take place in an appropriate court of law. Under state law, you may not begin court proceedings prior to the expiration of sixty (60) days after the date you filed your claim. In no event may legal action be taken against us later than three (3) years from the date you were required to file the claim. For members covered by a group (employer sponsored) health plan, your plan may be subject to the Employee Retirement Income Security Act of 1974 (ERISA), as amended. Under federal law, if your plan is subject to ERISA you may have the right to bring legal action under section 502(a) of ERISA after you have exhausted all appeals available under the plan. That means, for both medical and administrative appeals, federal law requires that you pursue a final decision from the plan, prior to filing suit under section 502(a) of ERISA. For a medical appeal, that final decision is the determination of the appeal. You are not required to submit your claim to external review prior to filing a suit under section 502(a) of ERISA. Consult your employer to determine whether this applies to you and what your rights and obligations may be. If you are dissatisfied with the decision on your claim, and have complied with applicable state and federal law, you are entitled to seek judicial review. This review will take place in an appropriate court of law.

  • No Challenge Stockholder agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, Merger Sub, the Company or any of their respective successors or directors (a) challenging the validity of, or seeking to enjoin the operation of, any provision of this Parent Support Agreement or (b) alleging a breach of any fiduciary duty of any Person in connection with the evaluation, negotiation or entry into the Merger Agreement.

  • No Proceedings or Litigation No action, suit or proceeding before any arbitrator or any governmental authority shall have been commenced, and no investigation by any governmental authority shall have been threatened, against the Company or any Subsidiary, or any of the officers, directors or affiliates of the Company or any Subsidiary seeking to restrain, prevent or change the transactions contemplated by this Agreement, or seeking damages in connection with such transactions.

  • Outcome a desirable situation, condition, or circumstance in a member’s life that can be a result of the support provided by effective care management. Outcomes defined include:

  • Legal Proceedings Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no legal, governmental or regulatory investigations, actions, suits or proceedings pending to which the Company or any of its subsidiaries is or may be a party or to which any property of the Company or any of its subsidiaries is or may be the subject that, individually or in the aggregate, if determined adversely to the Company or any of its subsidiaries, could reasonably be expected to have a Material Adverse Effect; no such investigations, actions, suits or proceedings are threatened or, to the knowledge of the Company, contemplated by any governmental or regulatory authority or threatened by others; and (i) there are no current or pending legal, governmental or regulatory actions, suits or proceedings that are required under the Securities Act to be described in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and (ii) there are no statutes, regulations or contracts or other documents that are required under the Securities Act to be filed as exhibits to the Registration Statement or described in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so filed as exhibits to the Registration Statement or described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.

  • Patent Challenge 6.5.1 Licensor may terminate this Agreement, effective immediately upon written notice to Licensee, upon the commencement by Licensee or any of its Affiliates of a Patent Challenge.

  • No Lawsuits No suit, action or other proceeding or investigation shall be threatened or pending before or by any Court or Government concerning this Agreement or the consummation of the transactions contemplated hereby. No Government shall have threatened or directed any request for information concerning this Agreement, the transactions contemplated hereby or the consequences or implications of such transactions to Buyer, to Seller, or to any officer, director, employee or agent of it.

Time is Money Join Law Insider Premium to draft better contracts faster.